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Cancer cells often use an altered metabolic pathway
in which glycolysis, uncoupled from the citric acid
cycle, serves as the primary source of ATP. To support
cancer cell proliferation and growth, the glycolytic
enzyme glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) must have a constant source of NAD. While
lactate dehydrogenase (LDH) in its conversion of
pyruvate to lactate is a well-known source of cytosolic
NAD for GAPDH activity, cytosolic malate
dehydrogenase (MDH1) also plays a role in cell
proliferation through its generation of cytosolic NAD
by the conversion of OAA to malate. This development
has implicated MDH1 in cancer cell metabolism and
characterizing the interactions of its different isoforms
with alternate substrates serves as a potential route to
cancer treatments. In this study, we created a G148T
mutant of human cytosolic malate dehydrogenase
isoform 3 (hMDH1) using site-directed mutagenesis to
survey potentially altered substrate specificity with
oxaloacetate (OAA) and α-ketoglutarate (αKG). We
produced a sample of both the mutant enzyme and the
wild type enzyme (WT hMDH1) by overexpression in
Escherichia coli and purification by Ni-NTA affinity
chromatography. We assessed the purity of the
enzyme samples using SDS-PAGE and determined the
protein concentration of each sample using a
bicinchoninic acid (BCA) assay. We performed kinetics
assays of the G148T hMDH1 mutant with OAA αKG
to determine enzyme activity relative to the wild type
using a modified Michaelis Menten model. This study
demonstrates that the G148T hMDH1 mutant enzyme
has decreased turnover rate and proficiency with OAA
compared to the wild type enzyme and that αKG is
likely not a viable substrate for hMDH1 isoform 3.
The enzyme malate dehydrogenase (MDH) reversibly
catalyzes the redox conversion of malate and oxaloacetate
(OAA) with the co-substrate NAD/NADH. At least two
forms of MDH exist in most eukaryotes: a mitochondrial
form (MDH2) which functions as the last step of the citric
acid cycle, and a cytosolic form (MDH1) which is

involved primarily with the malate/aspartate shuttle, which
exchanges reducing equivalents in the form of malate and
aspartate across the mitochondrial membrane (1,2). The
two forms have a relatively low extent of primary structure
similarity, with only 19.6% identity between
mitochondrial and cytosolic porcine MDH, and the
enzyme systems can function independently from one
another (1,3,4). Both forms of MDH generally exist as
dimers, and each subunit contains two domains: an NADbinding domain and a substrate binding domain (1). In
addition to malate and OAA, citrate is also known to bind
to the substate binding domain as an inhibitor of the
enzyme (1). Different isoforms of each type of MDH exist,
and characterizations of these different isoforms are
currently underway through an MDH course-based
undergraduate research experience (CURE) program of
which this research is associated (5).
Cytosolic MDH has recently been implicated in the
proliferation of cancer cells, which typically have altered
metabolism, relying heavily on glycolysis uncoupled from
the citric acid cycle to sustain cell growth and division (4).
To sustain glycolysis, a steady supply of cytosolic NAD is
necessary, which acts as an electron acceptor and cofactor
in the reaction catalyzed by glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). Generation of NAD for this
reaction has been known to come from lactate
dehydrogenase (LDH), which converts pyruvate to lactate,
however, an alternative source of cytosolic NAD has been
shown to also come from MDH1 (4). Deuterium labeling
studies conducted by Hanse et al. revealed that malate is a
significant hydrogen bond acceptor during cell
proliferation, and that MDH1 knockout cells proliferated
more slowly and consume less glucose than cells with
functional MDH1. In addition, studies indicate that MDH1
is amplified in solid tumor cancer cells (4).
Malate dehydrogenase enzymes are known to be highly
selective for OAA and malate as substrates, and rational,

single amino acid mutations have been applied as a
strategy to manipulate MDH substrate specificity (3).
These studies have demonstrated the importance of residue
composition and structural conformation of the active site,
including a flexible loop region covering the active site,
for selection of alternative substrates such as αketoglutarate (αKG) (3). In this study, one such rational,
single amino acid mutation is made to human cytosolic
malate dehydrogenase isoform 3 (hMDH1) with the sitedirected mutagenesis of glycine at position 148 in the wildtype hMDH1 isoform 3 enzyme (EC: 1.1.1.37; Uniprot:
P40925-3) to a threonine. This mutation yielded a viable,
soluble enzyme, and enzyme kinetics relative to the wild
type hMDH1 (WT hMDH1) indicated that the G148T
mutant hMDH1 showed decreased activity with the OAA
substrate compared to the WT hMDH1 while both the wild
type and the mutant showed little to no activity with αKG
as an alternative substrate.

Results
Visualization of hMDH1
Potential targets for site-directed mutagenesis were
identified using a multiple sequence alignment. The
sequence alignment included 29 different MDH protein
sequences spanning a diverse selection of organisms.
Conserved residues across all MDH proteins from the
alignment were not considered for mutation. In the interest
of influencing hMDH1 substrate specificity, potential
mutations were considered around a flexible loop region
near the active site on which, many charged, hydrophilic
residues extend outward. The residues located on the loop
(Figure 1, yellow) are highly conserved across MDH
enzymes and are thought to have an effect on the enzyme’s
likelihood of binding substrate from the cytosol (3). The
conformation of the loop also directly influences the size
of the active site (3). The residue glycine 148 (Figure 1A,B,
magenta) was hypothesized to be a promising location for
mutation due to its location immediately adjacent to the
active site loop (Figure 1B). Changing a glycine for a
larger residue was hypothesized to shift the loop region
and potentially increase the size of the active site. With this
logic, a threonine at the 148 position (Figure 1C, magenta)
was introduced in PyMol to visualize what might happen
to the loop region (6). While there is not currently a
structure for cytosolic human MDH (hMDH1), the
conformational changes that might be induced by a G148T
mutant are depicted in porcine MDH (Figure 1, PDB code
5MDH), which has 95.5% identity (Uniprot) to human
MDH.

Figure 1. Proposed mutation at residue 148. A, A view of the alpha
subunit of hMDH1 isoform 3, providing a macroscopic view of MDH,
the position of the loop (yellow), the binding sites of NADH (white) and
malate (cyan) substrates, as well as residue 148 (magenta). B, A view
of the wild type enzyme with glycine at residue 148. C, The proposed
G148T mutant. The larger threonine residue at position 148 changes
the conformation of the active site loop.

Preparation of pET28a plasmid vector
Before proceeding with site-directed mutagenesis,
preparation of an expression vector containing the hMDH1
isoform 3 gene was necessary. This process was expedited
with the generous gift of a pET28a plasmid containing the
hMDH1 isoform 3 gene from Dr. Jessica Bell and
colleagues at the University of San Diego. The plasmid
was isolated from E. coli BL21(DE3) cells with a yield of
125 ng/μL and a 260/280 ratio of 1.96 (Figure 2), which
falls within the typical range of 1.8-2.0 for pure DNA (7).
The 260/230 ratio was slightly high for DNA at 2.45 from
an expected range between 2.0-2.2, potentially indicating
inconsistencies between the pH or ionic strength of the
blanking solution compared to the sample solution (8). The
isolated pET28a vector containing hMDH1 was used as a
template in site-directed mutagenesis PCR.

sequencing (Genewiz), which indicated
introduction of the G148T mutation.

successful

Overexpression and purification of hMDH1
Purified protein samples of both the wild type hMDH1
and the G148T mutant hMDH1 enzymes were prepared for
downstream kinetics assays. The isolated pET28a
expression vectors for the wild type and G148T mutant
hMDH1 isoform 3 protein were each transformed into
Zymo Research E. coli Xjb (DE3) cells for overexpression.

Site-directed mutagenesis
The nucleotides that corresponded to glycine 148 were
located and primers were designed to introduce the
mutation to threonine with the altered codon ACT from the
wild type glycine codon GGT through PCR. The PCR
product was visualized using agarose gel electrophoresis
to confirm the presence of an intact plasmid containing the
hMDH1 gene (Figure 3). The expected amplicon for the
pET28a plasmid is present at 6292 bp, suggesting that the
site-directed mutagenesis primers successfully annealed to
the substrate and likely introduced the desired point
mutation. The PCR product was then circularized by
kinase, ligase, DpnI (KLD) treatment. The kinase in the
treatment first phosphorylates the 5’ ends of the plasmid,
then ligase seals gaps in the plasmid’s DNA
phosphodiester backbone for circularization. Finally, the
endonuclease DpnI degrades any remaining non-mutated
template DNA in the mixture (9). The circularized, KLD
treated plasmid was successfully transformed into NEB 5alpha E. coli cells (Figure 4). Many colonies are visible
against the Luria Bertani (LB) and kanamycin solid culture
medium, indicating that the pET28a plasmid vector
containing a kanamycin resistance gene was successfully
transformed into the cells. The pET28a plasmid containing
the putative G148T hMDH1 mutant gene was then isolated
with a yield of 40 ng/μL (Figure 5). The 260/280 ratio of
this plasmid sample is slightly greater than desired at 2.15
(optimal between 1.8-2.0), however, this does not indicate
any issues with sample quality. The 260/230 ratio is very
high, although still acceptable as this does not usually
indicate the presence of contaminants (7). The identity of
the plasmid sample was determined using Sanger

Figure 2. Absorbance spectrum of isolated pET28a vector containing
wild type hMDH1. A distinct peak is visible at 260 nm, indicating a
pET28a DNA sample of good quality. The sample is relatively
concentrated at 125 ng/μL.

Figure 3. Gel electrophoresis of site-directed mutagenesis PCR
product. This gel indicates the presence of the pET28a expression
vector containing the hMDH1 gene. While this gel does not indicate
successful introduction of the G148T mutation, the intensity of the
band at 6292 bp suggests that the site-directed mutagenesis primers
successfully annealed to the substrate and likely introduced the
desired G148T mutation. The gel also demonstrates that the PCR
mixture does not contain significant quantities of smaller molecular
weight DNA fragments.

Figure 4. Transformation into NEB E. coli 5-alpha cells. Many colonies
are present on the LB + kanamycin plate. This indicates that the cells
contain the pET28a plasmid with the kanamycin resistance gene,
indicating successful transformation.

The transformation efficiency of the cells containing the
G148T mutant hMDH1 gene was 62.5 CFU/μg DNA
(Figure 6). Single colonies from each transformation were
picked and cultured overnight in an LB + kanamycin liquid
medium, then expanded. Overexpression of the target
enzymes and autolysis of cells was induced, then the wild
type and G148T mutant hMDH1 enzymes were each
purified from the Xjb cell lysate by Ni-NTA affinity
chromatography. The Ni-NTA ligand of the column’s
solid phase adheres to a histidine tag added to the carboxy
terminus of the protein by the pET28a expression vector.
Washes with 25 mM imidazole followed by elution with
250 mM imidazole yielded the desired protein. The lysate,
flowthrough, washes, and eluent were each assessed for
the presence of the target protein by SDS-PAGE (10)
(Figure 7A). The lysate (Mut Lys) contained a complex
mixture of cellular proteins, including the overexpressed
target protein. The flowthrough (Mut FT, WT FT)
contained most of the cellular proteins with no significant
indication of target protein. The wash (Mut Wash)
contained a small amount of protein that had weak or
partial affinity to the column, while the eluent (Mut Elu,
WT Elu) contained a concentrated amount of the purified
protein with minimal contaminants (Figure 7A). The
Benchmark ™ prestained protein ladder was also used to
determine the molecular weight of the overexpressed WT
hMDH1 protein and the G148T hMDH1 mutant protein.
To do this, the square root of the molecular weight of the
ladder was plotted as a function of the log of the distance
migrated down the gel (Figure 7B). This generated a
standard curve from the protein ladder that could be used

to determine the molecular weight of the overexpressed
hMDH1 proteins by measuring the distance traveled in the
gel. Using this method, the molecular weight of the WT
hMDH1 was determined to be 32.1 kDa and the molecular
weight of the G148T hMDH1 mutant was determined to
be 31.6 kDa. This differed from molecular weights
determined in silico (Benchling), which calculated a
theoretical molecular weight of 39.7 kDa for both
enzymes.

Figure 6. Transformation of pET28a containing the G148T mutant
hMDH1 enzyme into Zyme E. coli Xjb (DE3) cells. Five colonies are
present on the LB + kanamycin plate. Although the transformation was
successful, this indicates low transformation efficiency.

spectrophotometrically by absorbance at 340 nm. The
observed rate as a function of OAA substrate concentration
was then plotted and fit using a modified Michaelis
Menten equation (12) (Figure 9A,B). The alternative
substrate α-ketoglutarate (αKG) was also surveyed for
activity with both the WT hMDH1 and the G148T hMDH1
mutant, and the kinetic constants are reported (Table 1).
The observed rate as a function of αKG substrate
concentration was also determined from the change in
absorbance at 340 nm (Figure 9C,D).
Figure 8. BCA assay standard curve. The standard curve was
constructed from BSA standards with known concentrations.

BCA assay
The protein concentration of WT hMDH1 and G148T
mutant hMDH1 eluent samples were each determined by
a bicinchoninic acid (BCA) assay (11). A set of standards
was prepared from bovine serum albumin (BSA) and the
absorbance was measured at 562 nm. The protein
concentration of the hMDH1 eluent samples were
determined using the BSA standard curve (Figure 8). The
concentration of the wild type hMDH1 eluent sample was
determined from an average of 6 assays done in triplicate
for an average of 0.61 mg/mL. The concentration of the
G148T mutant hMDH1 eluent, determined from a single
set of triplicate samples was 0.75 ± 0.01 mg/mL.
Enzyme Kinetics
The kinetic constants ksp, kcat, and KM for the WT
hMDH1 and G148T mutant hMDH1 were each
determined (Table 1) from the observed rate of conversion
from OAA to malate with the consumption of NADH
(kobs). The consumption of NADH was monitored

Table 1
Kinetic constants for WT hMDH1 and the G148T mutant hMDH1 with
native substrate OAA and alternate substrate αKG
kcat (s-1)
ksp (μM-1 s-1)
KM (μM)
WT OAA
320 ± 10
18 ± 2
18 ± 2
G148T OAA 2.3 ± 0.1
0.038 ± 0.002
60 ± 4
WT αKG
0.4 ± 0.2
{70 ± 900,000}
{0.005 ± 70}
G148T αKG 0.2 ± 0.1
{80 ± 2.0 × 107} {0.003 ± 500}

Discussion
This study has successfully generated a single amino
acid mutation in hMDH1 isoform 3 (G148T) and surveyed
its activity with the substrates OAA and αKG relative to
the WT hMDH1. The goal of site-directed mutagenesis
with hMDH1 was to make a targeted, rational amino acid
mutation and assess consequent substrate activity and
specificity. The replacement of glycine at position 148
with a bulkier threonine residue was designed to change
the conformation of the active site and flexible loop region
which closes over the active site (Figure 1). This loop
region is highly conserved across MDH enzymes and is
thought to significantly affect substrate binding in solution
(3).

All results related to site-directed mutagenesis,
subsequent transformations, protein overexpression, and
purification indicate the successful creation of the intended
G148T hMDH1 mutation. With the 6292 bp amplicon
indicating an intact pET28a vector containing the hMDH1
gene, the agarose gel electrophoresis following sitedirected mutagenesis PCR indicated successful annealing
of the mutagenesis primers to the substrate pET28a vector
containing the WT hMDH1 gene (Figure 3).
Circularization of the linear PCR product by KLD
treatment and transformation into NEB 5-alpha E. coli
cells also suggested success because the solid media is
supplemented with kanamycin and colonies only form
with the presence of the pET28a vector which contains a
kanamycin resistance gene (Figure 4). The plasmid was
isolated from the NEB 5-alpha cells with acceptable purity
(a 260/280 ratio of 2.15) and concentration at 40 ng/μL
(Figure 5). Sequencing of the plasmid (Genewiz)
confirmed the successful codon swap from GGT to ACT,
which encode glycine and threonine, respectively.

Transformation of the pET28a expression vector
containing the desired mutation into E. coli Xjb cells was
also successful, albeit with low transformation efficiency
at 62.5 CFU/μg of DNA (Figure 6). Subsequent
overexpression of MDH, cell lysis, and protein
purification by affinity chromatography were also
successful as indicated by SDS-PAGE with the different
eluents from Ni-NTA affinity chromatography (Figure
7A). The lanes labeled “Mut Elu” and “WT Elu”, each
show the purified samples containing the G148T hMDH1
mutant enzyme and WT hMDH1, respectively. These
lanes each show an intense band around 32 kDa, which
matches the approximate molecular weight of hMDH1,
which Benchling analysis predicts at ≈ 40 kDa and Uniprot
reports as 38.6 kDa. A more precise determination of the
molecular weight of the proteins was an analysis of the gel
using the protein ladder as a standard curve (Figure 7B).
This method was used to determine a molecular weight of
31.6 kDa for the mutant hMDH1, and 32.1 kDa for the WT
hMDH1. This apparent 6-8 kDa discrepancy between the

predicted molecular weight might be ameliorated by a
smaller amount of protein loaded on the gel, which might
produce a less intense band that could be more precisely
measured relative to a protein ladder of known molecular
weight. With the purified protein present in the sample, a
BCA assay was performed to determine its concentration.
Using the standard curve of BSA standards, the protein
concentration of the G148T hMDH1 mutant sample was
determined as 0.75 ± 0.01 mg/mL while an average for the
concentration of the WT hMDH1 sample was determined
as 0.61 mg/mL from a larger dataset.
The activity of the WT hMDH1 sample and the G148T
hMDH1 mutant were assessed using the substrates OAA
and αKG, yielding mixed results. For WT hMDH1 with
OAA, kcat was determined as 320 ± 10 s-1, ksp was 18 ± 2
μM-1 s-1, and KM was 18 ± 2 μM. These results set a
baseline for the activity of the native enzyme but appear
much lower than some literature values which report a kcat
around 780 s-1 (2,13). The G148T hMDH1 mutant had a
much lower turnover rate than the WT, with kcat at 2.3 ±
0.1 s-1 and a lower specificity with ksp at 0.038 ± 0.002
μM-1 s-1. This lower turnover and specificity manifests in
the KM, which was approximately 3 times greater than the
KM of the wild type at 60 ± 4 μM. This result indicates that
the G148T mutant was less efficient at converting OAA to
malate with the consumption of NADH than the WT
enzyme. These results demonstrate agreement with the
hypothesis that the threonine mutation at position 148
would change the conformation of the active site and
influence enzyme function and substrate specificity.
The alternative substrate αKG produced inconclusive
results with the kinetics assays performed on both the WT
and mutant hMDH1 enzymes. Malate dehydrogenase has
inherently strong specificity for OAA and malate as
substrates, and although αKG has previously been
described as an alternative substrate for MDH, its observed
reaction rate is noted as 10,000-fold less than with OAA
(2,3). The kinetics assay conducted in this study was not
refined enough to appreciably represent this difference in
the activity. The kcat values for both the WT hMDH1 and
the G148T hMDH1 mutant were close to zero, at 0.4 ± 0.2
s-1 and 0.2 ± 0.1 s-1, respectively, each with 50% error. The
remaining kinetic values were associated with tremendous
amounts of error and were inconclusive (Table 1). To
detect MDH activity with the αKG alternative substrate,
the assay conditions will need to be refined to obtain
optimal precision for detection of activity 10,000-fold less
than with OAA. This would include further manipulation
of substrate and enzyme concentrations in the assay to

obtain the best possible absorbance changes over time.
However, in only considering the data presented here, it
appears that αKG is not a viable substrate for hMDH1
isoform 3.
A potential source of error with the αKG kinetics assay
was the presence of a contaminant species which also
absorbed at 340 nm. Upon addition of the αKG substrate
to the assay mixture, absorbance increased sharply from
0.8 to 1.2, and an absorbance spectrum of the αKG stock
solution indicated a weakly absorbing species with a peak
at 320 nm (data not shown). Further investigation of this
phenomenon might be necessary to obtain precise kinetic
data for αKG, as other chemical species in the assay
mixture might interfere with the absorbance signal.
Relative to the broad goals of this research, further
work must be done to conclusively determine the effect of
the G148T hMDH1 mutation. It is evident that this
mutation changed the active site conformation of the
enzyme, decreasing the enzyme’s proficiency to convert
OAA to malate, but the mutation’s effect on substrate
specificity is still unknown with the inconclusive result of
kinetic assays with αKG. Future studies might define the
optimal conditions for kinetics using αKG or investigate
additional alternative substrates or inhibitors of the
enzyme. Inhibition of mutated MDH enzymes might be
particularly relevant in relation to cancer, as specificity for
an inhibitive alternative substrate might provide valuable
data to develop cancer treatments by stunting cancer cell
glucose metabolism with decreased availability of
cytosolic NAD for the glycolytic enzyme GAPDH (4).

Experimental Procedures
Preparing liquid cultures
Liquid cultures were inoculated from E. coli
BL21(DE3) cells containing hMDH1 isoform 3 streaked
on a plate generously provided by Dr. Jessica Bell at the
University of California San Diego. Cells were grown up
in Luria-Bertani (LB) medium pH 7.5 (1% tryptone, 0.5%
yeast extract, 1% NaCl) with 50 μg/mL kanamycin using
a baffled flask. Cultures were grown for 14-22 hours at
28°C shaking 250 rpm.
Plasmid isolation from E. coli
Cultures of E. coli BL21(DE3) with a pET28a plasmid
containing the hMDH1 isoform 3 gene were grown to an
OD600 between 4-6. A 3 mL volume of E. coli cells were
pelleted and resuspended in water before processing. The
Zymo Research Zyppy Plasmid Miniprep kit was used for

the remaining plasmid isolation and instructions were
followed as provided by Zymo.
An additional
centrifugation of 16,000 × g for 4 minutes was done after
adding neutralization buffer to account for puffy protein
precipitate. Another additional centrifugation of 13,000 ×
g was done to remove any residual Zyppy Wash buffer
before elution. Elution was done with 10 mM Tris pH 7.5
prewarmed to 50°C and allowed to incubate on the Zymo
spin column for 20 minutes before centrifugation to elute.
The concentration of plasmid DNA was measured using
the
Thermo
Scientific
Nanodrop™
1000
Spectrophotometer.
Site-directed mutagenesis
To introduce the G148T mutation, site-directed
mutagenesis of hMDH1 isoform 3 on the pET28a
expression vector was done using the Q5® Site-Directed
Mutagenesis Kit (New England BioLabs). Amino acid
mutations were codon optimized for E. coli and introduced
by PCR with complementary primers designed using
NEBaseChanger (New England BioLabs). In the PCR
mixture, 25 ng of pET28a DNA was used as the template
with
the
forward
primer
TATTGTTGTGactAATCCAGCCAATACC and the reverse
primer ACCTTAACTGACTTCTTG, where lowercase
nucleotides in the forward primer represent alterations for
the desired codon change from glycine to threonine. The
following PCR protocol was used: 98°C initial
denaturation for 30 seconds, 30 cycles of 98°C
denaturation (10 seconds), 56°C annealing (30 seconds),
and 72°C extension (2 minutes 30 seconds), followed by a
final extension of 72°C for 2 minutes. The result of the
reaction was visualized on a 1% agarose gel in TBE (89
mM Tris, 89 mM boric acid, 2 mM EDTA) precast with
SYBRsafe (Invitrogen). Quick Load® Purple 1kb Plus
DNA Ladder (New England BioLabs) was used as a
reference to identify amplicons. The hMDH1 DNA
sequence containing the G148T mutation introduced by
PCR was then treated with KLD reaction buffer and KLD
enzyme mix provided with the Q5® Site-Directed
Mutagenesis Kit (New England BioLabs). The KLD
treatment was done to circularize the linear PCR product
containing the G148T mutation. The KLD treated,
circularized plasmid was then transformed into chemically
competent NEB® High Efficiency DH5α E. coli cells
(New England BioLabs) for replication of pET28a
containing the hMDH1 G148T mutation. The KLD
mixture was added to the cells and placed on ice for 30
minutes. The cells were then heat shocked at 42°C for 30
seconds. Following heat shock, the cells were placed on

ice for 5 minutes, then combined with room temperature
SOC media (2% vegetable peptone, 0.5% yeast extract, 10
mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4,
20 mM glucose) and incubated at 37°C for 1 hour shaking
250 rpm. Cells were pelleted by centrifugation at 3,000 ×
g for 3 minutes and resuspended in 100 μL of water. The
resuspension was then cultured on solid LB medium (3%
agar) containing 50 μg/mL kanamycin. The plate was
incubated at 37°C overnight. A resulting colony was then
picked and expanded in a liquid culture with LB and 50
μg/mL kanamycin. The plasmid was then isolated and
sequenced (Genewiz) to confirm the plasmid’s sequence
identity with the intended G148T mutant sequence prior to
protein overexpression.
Protein overexpression
For both the wild type hMHD1 isoform 3 plasmid and
the G148T hMDH1 isoform 3 mutant, the pET28a
expression vectors were transformed into E. coli Xjb
(DE3) cells (Zymo Research, product # T3051). Cells
were thawed on ice, 40 ng of DNA was added, and cells
were incubated on ice for 10 minutes. Following
incubation on ice, 4 volumes of SOC medium were added
and the cells were incubated for 1 hour shaking at 150 rpm.
Cells were pelleted by centrifugation at 3,000 × g for 3
minutes, supernatant was discarded, and the pellet was
resuspended in 100 μL of medium. The resuspension was
plated on LB supplemented with 50 μg/mL kanamycin and
incubated at 37°C overnight. A resulting colony was
propagated in liquid LB medium with 50 μg/mL
kanamycin at 37°C shaking 250 rpm overnight, then
expanded to an OD600 of 0.5-0.6. Protein expression and
autolysis were induced by addition of IPTG to a
concentration of 0.5 mM and arabinose to a concentration
of 3 mM, respectively. Cells were grown overnight at
20°C shaking 250 rpm and harvested the next day by
centrifugation at 3,000 × g and 4°C for 10 minutes. The
resulting pellet was frozen at -20°C.
Cell lysis and affinity chromatography
After overexpression, frozen E. coli Xjb (DE3) cells
were thawed on ice, then refrozen with liquid nitrogen and
rethawed on ice. This introduced an additional freeze-thaw
cycle. The cells were then resuspended in a volume of lysis
buffer (20 mM Tris, 100 mM NaCl, pH 8.0) based on cell
weight (3 mL/g). The lysis buffer was supplemented with
a Pierce™ Protease Inhibitor tablet (Thermofisher,
A3255), 1 mg of lysozyme, and 30 units of DNAse I
(VWR, 0649-50KU). The mixture was incubated at 37°C
shaking 200 rpm for 30 minutes to facilitate resuspension

and cell lysis. The cell lysate was then pelleted by two
rounds of centrifugation at 21,130 × g and 4°C for 5
minutes. The pellet was discarded, and supernatant lysate
was mixed with an equal volume of equilibration buffer
(PBS, 20 mM sodium phosphate, 300 mM sodium
chloride, pH 7.4) and a 2 mL bed of Ni-NTA resin by endover-end rotation for 30 minutes at 4°C. The resulting
slurry was added to a glass column and the flow through
was collected. Following the initial flow through, washes
consisting of PBS (phosphate-buffered saline: 20 mM
sodium phosphate, 300 mM sodium chloride, pH 8) with
25 mM imidazole were done until the absorbance at 280
nm was less than 0.100, at which point hMDH1 was eluted
from the column using 3 resin bed volumes of PBS
containing 250 mM imidazole. The hMDH1 eluent was
then dialyzed using dialysis membrane tubing
(Spectra/Por, 12,000-14,000 molecular weight cutoff) in
dialysis buffer (10 mM potassium phosphate, 0.1 mM
EDTA, pH 8.0) stirring at 4°C. Fresh dialysis buffer was
applied twice, once after 20 hours, and the second time
after 70 hours.

then by repeated washing in destaining solution (40%
methanol, 7% acetic acid, 3% glycerol) while shaking. The
destained gel was then dried using a vacuum gel dryer.
Enzyme Kinetics Assay
The kinetics of both the WT hMDH1 and the G148T
mutant
hMDH1
sample
were
assessed
spectrophotometrically by tracking the consumption of
NADH over 10 seconds at 340 nm. For the WT hMDH1,
enzyme to a final concentration of 1 nM, NADH to a final
concentration of 0.13 mM, and OAA to varying
concentrations between 0.005-0.313 μM were added to a
3000 μL volume of potassium phosphate buffer (100 mM,
pH 7.5). The change in absorbance over time was
monitored with different concentrations of OAA, and the
reaction velocity as a function of OAA substrate
concentration was plotted using a modified Michaelis
Menten equation (12). The kinetic constants, ksp, kcat, and
KM were then determined from the equation below.
𝑣=

BCA Assay

𝑘𝑆𝑃 [𝑆]
1 + 𝑘𝑆𝑃 [𝑆]/𝑘𝑐𝑎𝑡

Where
To determine the concentration of hMDH1 protein
samples, a bicinchoninic acid (BCA) assay for the
colorimetric detection and quantification of protein was
performed (11). This was done using the Pierce™ BCA
Protein Assay Kit (Product #23209) using the test-tube
protocol at room temperature as described in the product
user guide. All volumes listed in the test-tube protocol
were reduced by half.
SDS-PAGE
The purity of the WT hMDH1 and G148T mutant
hMDH1 eluent samples were assessed by SDS-PAGE as
described previously (10) with minimal changes. A 4%
acrylamide stacking gel and a 12% acrylamide separating
gel were made. The sample buffer was prepared using
0.03125 M Tris, 1% SDS, 12.5% glycerol, and 0.005%
bromophenol blue. Samples were added to sample buffer
and boiled for 5 minutes to dissociate proteins. A volume
of sample was loaded on the gel to deliver between 5-100
ng of protein, and wells were topped off with Tris/glycine
reservoir buffer (0.025 M Tris, 0.192 M glycine and 0.1%
SDS, pH 8.3) (10). The samples were loaded on the gel
and the gel was run at a constant 200 volts for 45 minutes.
The gel was then stained in Coomassie Blue staining
solution (0.025% Coomassie Blue R-250, 40% methanol,
7% acetic acid) overnight. The gel was destained by
repeated washing with water and heating in a microwave,

𝐾𝑀 =

𝑘𝑐𝑎𝑡
𝑘𝑠𝑝

In the equation above, v is the reaction velocity, [S] is the
concentration of substrate, kcat is the maximum turnover
(kcat) and proficiency of the enzyme (kcat/kuncat), and ksp is
the specificity and efficiency of the enzyme (kcat/KM).
A kinetics assay of an alternative substrate αketoglutarate (αKG) was also performed.
The
concentration of NADH was spectrophotometrically
monitored at 340 nm over a period 20 seconds. For the WT
hMDH1, enzyme to a final concentration of 204 nM,
NADH to a final concentration of 0.14 mM, and αKG to
varying concentrations between 48-3000 μM were added
to a 3000 μL volume of potassium phosphate buffer. The
change in absorbance over time was monitored with
different concentrations of αKG, and the reaction velocity
as a function of αKG substrate concentration was plotted
using the modified Michaelis Menten equation above. The
kinetic constants, ksp, kcat, and KM were also determined for
the WT hMDH1 and the G148T hMDH1 mutant enzymes.
The data was processed and plotted using Mathematica.
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